COVID-19 Preprints

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent preprints published on COVID-19.

August 15, 2020
Open Access

Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate

BioRxiv : the Preprint Server for Biology
Sandhya BangaruAndrew B Ward
August 13, 2020
Preprint

Attenuated influenza virions expressing the SARS- CoV-2 receptor-binding domain induce neutralizing antibodies in mice

BioRxiv : the Preprint Server for Biology
A. N. LoesJesse D Bloom
August 15, 2020
Open Access

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

BioRxiv : the Preprint Server for Biology
Sho IketaniDavid D Ho
August 15, 2020
Open Access

Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing

MedRxiv : the Preprint Server for Health Sciences
Steven E ConklinOliver Laeyendecker
August 14, 2020
Preprint

Methylation of RNA Cap in SARS-CoV-2 captured by serial crystallography

BioRxiv : the Preprint Server for Biology
M. WilamowskiAndrzej Joachimiak
August 14, 2020
Preprint

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

BioRxiv : the Preprint Server for Biology
G. PapaLeo C James
August 15, 2020

Understanding the patterns of repeated testing for COVID-19: Association with patient characteristics and outcomes

MedRxiv : the Preprint Server for Health Sciences
Stephen SalernoBhramar G Mukherjee
August 15, 2020
Open Access

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays

MedRxiv : the Preprint Server for Health Sciences
Zahra Rikhtegaran TehraniMohammad M Sajadi
August 14, 2020
Preprint

SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2

BioRxiv : the Preprint Server for Biology
Nicholas S HeatonNicholas S Heaton
August 15, 2020
Open Access

Two Stage Designs for Phase III Trials

MedRxiv : the Preprint Server for Health Sciences
Dean Follmann, Michael Proschan
August 15, 2020
Open Access

Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity

BioRxiv : the Preprint Server for Biology
Hejun LiuIan A Wilson
August 15, 2020
Open Access

Clinical Mortality Review in a Large COVID-19 Cohort

MedRxiv : the Preprint Server for Health Sciences
Mark P JarrettKaren L Nelson
August 15, 2020
Open Access

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

BioRxiv : the Preprint Server for Biology
Longxing CaoDavid Baker
August 14, 2020
Preprint

Differential methylation as a mediator of COVID-19 susceptibility

BioRxiv : the Preprint Server for Biology
Sandra SteyaertW. Van Criekinge
August 15, 2020
Open Access

SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for reverse zoonosis to New World rodents

BioRxiv : the Preprint Server for Biology
Anna FagreTony Schountz
August 15, 2020

A phenome-wide association study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan Medicine

MedRxiv : the Preprint Server for Health Sciences
Maxwell SalvatoreBhramar G Mukherjee

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

© 2020 Meta ULC. All rights reserved
/feed-previews/covid-19-preprints/c3b66c4c-2f84-4fbe-b290-b39f2aa7d5d4